Evidence map›Paper›PMID 34586946›Full record

ArticlemAbs

Enhancing the multi-attribute method through an automated and high-throughput sample preparation.

Pongkwan Sitasuwan, Thomas W Powers, Tiffany Medwid, Yuting Huang, Bradley Bare, L Andrew Lee

Open access · goldAbstract read
In one paragraph

Article in mAbs. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Attribute Analytics Performance Metrics from the MAM Consortium Interlaboratory Study.Journal of the American Society for Mass Spectrometry · 2022
    Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Pongkwan SitasuwanIntegrated Micro-Chromatography Systems, Inc, Irmo, SC, USA.
Thomas W PowersPfizer, Inc, Chesterfield, MO, USA.
Tiffany MedwidPfizer, Inc, Chesterfield, MO, USA.
Yuting HuangPfizer, Inc, Chesterfield, MO, USA.
Bradley BarePfizer, Inc, Chesterfield, MO, USA.
L Andrew LeeIntegrated Micro-Chromatography Systems, Inc, Irmo, SC, USA.
Pfizer (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The multi-attribute method (MAM), a recent advance in the application of liquid chromatography-mass spectrometry within the pharmaceutical industry, enables the simultaneous monitoring of multiple product quality attributes in a single analytical method. While MAM is coupled with automated data processing and reporting, the sample preparation, based on proteolytic peptide mapping, remains cumbersome and low throughput. The standard sample preparation for MAM relies on protein denaturation, reduction, and alkylation prior to proteolytic digestion, but often a desalting step is required to maintain enzymatic activity. While most of the sample preparation can be automated on a standard robotic liquid handling system, a streamlined approach for protein desalting and temperature modulation is required for a viable, fully automated digestion. In this work, for the first time, a complete tip-based MAM sample preparation is automated on a single robotic liquid handling system, leveraging a deck layout that integrates both heating and cooling functionalities. The fully automated method documented herein achieves a high-throughput sample preparation for MAM, while maintaining superior method performance.

Indexed as

Immunoglobulin GChromatography, High Pressure LiquidChromatography, LiquidMass SpectrometryPeptide MappingImmunoglobulin Ghigh throughputMulti-attribute method (MAM)product quality attributessample preparation automation

Identifiers

PMID34586946
PMCPMC8489909
OpenAlexW3204727466

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.